IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Iambic Therapeutics, Inc.
$16.34−7.47 (-31.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Iambic Therapeutics from other investors
No posts about IAM yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.